Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bridgebio Pharma Inc (NQ: BBIO )

27.49 +1.05 (+3.97%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bridgebio Pharma Inc

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
45 Biggest Movers From Yesterday
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares climbed 64.8% to close at $19.02 on Tuesday as traders circulated a social media post on a potential short squeeze. ShiftPixy... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers BridgeBio Pharma (NASDAQ:BBIO) shares increased by 17.7% to $13.39 during Tuesday's regular session. Trading volume for this security as of 12:32 EST is 25.2... 
Via Benzinga
Why BridgeBio Pharma Shares Are Rising
BridgeBio Pharma Inc (NASDAQ: BBIO) is trading higher Tuesday as the stock rebounds after falling on Monday. BridgeBio Pharma shares traded lower Monday after the... 
Via Benzinga
Where BridgeBio Pharma Stands With Analysts
Within the last quarter, BridgeBio Pharma (NASDAQ:BBIO) has observed the fo... 
Via Benzinga
Unusual Options Activity Insight: BridgeBio Pharma
BridgeBio Pharma (NASDAQ:BBIO) shares experienced unusual... 
Via Benzinga
25 Stocks Moving In Tuesday's Mid-Day Session
Gainers Insignia Systems, Inc. (NASDAQ: ISIG) shares jumped 64.6% to $18.99 as traders circulated a social media post on a potential short squeeze. Flotek Industries, Inc. (NYSE... 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Argus Research raised Tesla, Inc. (NASDAQ: TSLA) price target from $1,010 to $1,313. Tesla shares rose 1.8% to $1,113.84 in pre-market trading. Needham boosted the price target... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 41.2% to $3.29 during Tuesday's pre-market session. The company's market cap stands at $47.1... 
Via Benzinga
51 Biggest Movers From Yesterday
Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares climbed 65.1% to close at $8.95 on Monday after the company announced a strategic collaboration with Stryker Corporation to... 
Via Benzinga
Mid-Afternoon Market Update: Dow Surges Over 200 Points; Microbot Medical Shares Spike Higher
Toward the end of trading Monday, the Dow traded up 0.64% to 36,181.37 while the NASDAQ rose 1.19% to 15,838.88. The S&P also rose, gaining 1.07% to 4,776.31. The U.S. has the... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 47.87% to $8.02 during Monday's regular session. The current volume of 63.6 million shares is 153229.83%... 
Via Benzinga
S&P 500 Nabs Fresh Intraday High Amid Extended Rally
Stocks are extending their post-holiday climb, with the Dow Jones Industrial Average up 200 points at midday. The S&P 500 Index also sports sizable gains, while the Nasdaq Composite is eyeing a notable... 
Via Talk Markets
Mid-Day Market Update: Nasdaq Rises 1%; BridgeBio Pharma Shares Plunge
Midway through trading Monday, the Dow traded up 0.54% to 36,146.21 while the NASDAQ rose 1.04% to 15,815.70. The S&P also rose, gaining 0.87% to 4,766.92. The U.S. has the... 
Via Benzinga
34 Stocks Moving In Monday's Mid-Day Session
Gainers Microbot Medical Inc. (NASDAQ: MBOT) shares jumped 69.6% to $9.19 after the company announced a strategic collaboration with Stryker Corporation to develop the LIBERTY... 
Via Benzinga
Why BridgeBio Pharma Shares Are Plummeting Today
BridgeBio Pharma Inc (NASDAQ: BBIO) is trading significantly lower Monday morning after the company announced that its Phase 3 trial to treat symptomatic transthyretin amyloid... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; News Corp To Buy Base Chemicals
Following the market opening Monday, the Dow traded up 0.39% to 36,089.53 while the NASDAQ rose 0.78% to 15,774.78. The S&P also rose, gaining 0.70% to 4,758.97. The U.S. has... 
Via Benzinga
BridgeBio Pharma Stock Crashes As Pfizer-Rivaling Heart Drug Flops
Patients who received the drug didn't improve in the six-minute walking test. 
Via Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Microbot Medical (NASDAQ:MBOT) stock moved upwards by 55.35% to $8.42 during Monday's pre-market session. The company's market cap stands at $59.8 million... 
Via Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts, and COVID-19 treatment and vaccine developments dictating sentiment. Here are the key... 
Via Talk Markets
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating... 
Via Benzinga
63 Biggest Movers From Friday
Gainers Spruce Biosciences, Inc. (NASDAQ: SPRB) jumped 102.8% to close at $5.03 on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and a $15... 
Via Benzinga
How Alnylam Pharmaceuticals Could Take On Pfizer With A 'Catalyst-Rich' 2022
Alnylam is working on a drug that could tackle transthyretin cardiomyopathy. 
Via Investor's Business Daily
BridgeBio Pharma Secures Debt Financing Of $750M
BridgeBio Pharma Inc (NASDAQ: BBIO) has executed a definitive credit facility agreement with a syndicate of lenders for up to $750 million in financing. This facility,... 
Via Benzinga
10 Biggest Price Target Changes For Monday
RBC Capital boosted Tesla, Inc. (NASDAQ:TSLA) pri... 
Via Benzinga
BridgeBio Pharma's Candidate For Muscle-Wasting Disorder Wins Fast Track Tag In US
The FDA has granted Fast Track Designation to BridgeBio Pharma Inc's (NASDAQ: BBIO) BBP-418 as a treatment option for Limb-girdle Muscular Dystrophy Type... 
Via Benzinga
Exposures Product Safety
BridgeBio Pharma and LianBio Announce First Patient Treated in Phase 2a Trial of Infigratinib in Patients with Gastric Cancer and Other Advanced Solid Tumors
From LianBio
Via Business Wire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Opiant Pharmaceuticals (NASDAQ:OPNT 
Via Benzinga
BridgeBio Pharma Stock Sees Rising Relative Strength; Still Shy Of Key Threshold
In a welcome move, biotech BridgeBio Pharma stock saw its Relative Strength Rating rise from 70 to 73 on Thursday. 
Via Investor's Business Daily
2 Top Biotech Stocks to Buy for Summer 2021
Progress in these companies' drug development pipelines should give shareholders plenty to look forward to. 
Via The Motley Fool
BridgeBio Stock Flashes Healthy 83 RS Rating
Look for stocks with a Relative Strength Rating of 80 or higher. BridgeBio stock just hit that mark, with a jump from 79 to 83 Wednesday. 
Via Investor's Business Daily
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.